-
111 Inc. Appoints Yang “Luke” Chen to Board of Directors Following Resignation of Dr. Lian Yong Chen
•
China-based online pharmacy 111 Inc. (NASDAQ: YI) has announced the appointment of its Senior Finance Executive, Mr. Yang “Luke” Chen, as a new director. This follows the resignation of Dr. Leon Lian Yong Chen from the company’s board due to personal reasons, effective immediately. Dr. Lian Yong Chen’s Background and…
-
ClouDr Receives NMPA Green Light for ClouDT-01, a Groundbreaking Digital Diabetes Treatment
•
Hangzhou Kang Ming Information Technology Co., Ltd, trading under the banner of “ClouDr” on the Hong Kong stock exchange (HKG: 9955), has announced that it has secured marketing approval from the National Medical Products Administration (NMPA) for its innovative digital medicine product, ClouDT-01, designed for the treatment of diabetes. Leveraging…
-
Alibaba Health Forges Strategic Partnerships with Viatris and Chinese Pharma Companies for Digital Health Expansion
•
Alibaba Health Information Technology Ltd (HKG: 0241), the health industry arm of Chinese e-commerce giant Alibaba Group, has announced strategic collaboration agreements with a consortium of pharmaceutical companies. The collaborations include US-based Viatris (NASDAQ: VTRS) and Chinese firms Qilu Pharmaceutical, Chongqing Taiji Industry (Group) Co., Ltd (SHA: 600129), Shandong Dyne…
-
Ant Group Eyes Acquisition of Leading Internet Healthcare Platform Haodf.com
•
Ant Group, the China-based fintech powerhouse, is reportedly pursuing the acquisition of Haodf.com, one of the country’s leading Internet healthcare platforms. This shift in negotiations comes after Alibaba Health Information Technology Ltd (HKG: 0241), Ant’s sister company, previously engaged in discussions with Haodf.com, according to local media sources. The two…
-
Shanghai Pharmaceuticals’ SH-INNO Incubator to Drive Biopharmaceutical Innovation and Collaboration
•
Shanghai Pharmaceuticals (SPH;HKG: 2607; SHA: 601607) has launched the “SH-INNO incubator,” a collaborative initiative with premier academic institutions and leading scientific research organizations. The incubator is designed to dismantle conventional silos and foster interdisciplinary collaboration among professionals, scholars, corporations, and financiers across the spectrum of “industry, academia, research, medicine, and…
-
WeDoctor Partners with Shanghai Children’s Medical Center to Enhance Pediatric Care
•
WeDoctor Holdings Ltd, a subsidiary of Chinese internet conglomerate Tencent Corporate Venture Capital (HKG: 0700) that specializes in online medical services, has entered into a strategic partnership with Shanghai Children’s Medical Center. While financial details of the agreement were not disclosed, the collaboration aims to combine WeDoctor’s expertise in digitalization…
-
E-Health Now Secures USD 13.8 Million in Series C Financing to Expand AI Medical Services
•
E-Health Now, a China-based one-stop artificial intelligence (AI)-powered medical health service platform, has reportedly secured nearly RMB 100 million (USD 13.8 million) in a Series C financing round. The funding round attracted notable investors such as Ameba Capital, Ventech China, and Borchid Capital. The capital raised is intended to fuel…
-
Digital Health China Partners with Huawei to Launch Intelligent Multimodal Big Data System for Healthcare
•
Digital Health China Technologies Co., Ltd., a leading cloud-based healthcare service provider based in China, has entered into a comprehensive partnership agreement with Huawei Technologies Co., Ltd., a global telecommunications giant. The collaboration aims to jointly launch an intelligent multimodal big data center system solution. This innovative solution harnesses the…
-
Winning Health Partners with Unicom Digitization Medical to Boost Medical Industry Innovation
•
Winning Health (SHE: 300253), a Shanghai-based company in the medical information industry, has entered into a partnership with Unicom Digitization Medical Technology Co., Ltd. The collaboration aims to combine their respective strengths in the medical and health sector to enhance product, service, and commercial innovation. The joint efforts will focus…
-
Eli Lilly & Co. Partners with OpenAI to Use Generative AI in Antimicrobial Drug Discovery
•
Eli Lilly & Co. (NYSE: LLY), a leading pharmaceutical company based in the U.S., has announced a drug collaboration agreement with OpenAI, a prominent artificial intelligence (AI) research organization headquartered in San Francisco. As part of this collaboration, Lilly will utilize OpenAI’s advanced generative AI technologies to develop innovative antimicrobial…
-
C.Q. Pharmaceutical and JD.com Join Forces to Revolutionize Pharmaceutical Supply Chain
•
C.Q. Pharmaceutical Holding Co., Ltd (SHE: 000950), a prominent Chinese pharmaceutical company, has announced a strategic partnership with China’s leading e-commerce platform, JD.com (NASDAQ: JD). The collaboration aims to innovate across various sectors, including consumer goods supply chain, pharmaceutical and medical services, wholesale and retail, warehousing and logistics, and supply…
-
Union Hospital Teams Up with Baidu Health for AI-Enhanced Outpatient Services
•
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, has entered into a strategic partnership with Baidu Health. This collaboration aims to focus on AI intelligent outpatient services, thereby strengthening the digital transformation of medical services. The hospital has demonstrated initial success with its AI intelligent outpatient system,…
-
Siemens Healthineers and Ruijin Hospital Collaborate to Build Medical Digital Human Metaverse
•
Siemens Healthineers AG, the German medical technology major, has entered into a strategic partnership with Ruijin Hospital, a Class 3A teaching hospital based in Shanghai. The collaboration aims at developing “Medical digital human metaverse application scenarios,” marking a significant step in the integration of metaverse technology into healthcare. Siemens Healthineers…
-
Vazyme Partners with Yufang Medical to Boost Alzheimer’s Blood Test Sales Online
•
Vazyme Biotech Co., Ltd (SHA: 688105), based in China, has entered into a strategic partnership with Shanghai Yufang Medical Technology (Group) Co., Ltd to enhance their collaboration in the screening and testing sector. Under the terms of the agreement, the two companies will leverage their respective strengths to jointly promote…
-
JD Healthcare Forges Partnerships with Top Medical Device Firms at CMEF
•
The China International Medical Equipment Fair (CMEF), which took place last week in Shanghai, was a significant event for JD Healthcare, a subsidiary of China’s e-commerce giant JD.com (NASDAQ: JD). The company announced a series of strategic partnerships with prominent medical device firms, including Yuyue Medical, Omron, Cofoe Medical, Philips,…
-
Zhejiang Dian Diagnostics Partners with Haihe Laboratory to Advance Hematology Diagnostics
•
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a company based in China, has entered into a strategic partnership with the Haihe Laboratory of Cell Ecosystem under the China Academy of Medical Sciences. The collaboration aims to drive research translation, standardize disease diagnosis and treatment, advance digital healthcare, and enhance discipline…
-
Baidu Health Partners with Yibang to Enhance Operations for Brick-and-Mortar Pharmacies
•
Baidu Health has entered into a strategic partnership with Shanghai Yibang Medicine Information Technology Co., Ltd., aiming to leverage Baidu’s extensive capabilities in search, mapping, health, artificial intelligence, and e-commerce to enhance operations for brick-and-mortar pharmacies across China. Financial terms of the agreement were not disclosed. The collaboration will focus…
-
CAIR Launches CARES Copilot 1.0: A Revolutionary AI Chatbot for Medical Diagnosis and Treatment
•
The Centre for Artificial Intelligence and Robotics (CAIR), part of the Chinese Academy of Sciences (CAS) in Hong Kong, has officially launched CARES Copilot 1.0, a cutting-edge chatbot powered by a large language model designed to assist medical professionals in diagnosis and treatment. CARES Copilot 1.0 integrates the vast knowledge…
-
ClouDr Inks Deal with CR Sanjiu to Boost Hospital Sales of Cardiovascular Medicine
•
Hangzhou Kang Ming Information Technology Co., Ltd, (HKG: 9955) trading under the moniker “ClouDr”, has entered into a partnership with CR Sanjiu (SHE: 000999), a state-owned pharmaceutical company specializing in treatments for cardiovascular and cerebrovascular diseases and endocrine disorders. Under this strategic alliance, ClouDr will serve as the general agent…
-
Innovent Biologics’ Taletrectinib Receives Second NDA Acceptance in China for ROS1 Positive NSCLC
•
Innovent Biologics Inc., (HKG: 1801), a biopharmaceutical company based in China, has announced that the Center for Drug Evaluation (CDE) in China has accepted a second New Drug Application (NDA) for its investigational drug taletrectinib. This next-generation tyrosine kinase inhibitor (TKI) targets ROS1 and NTRK fusion mutations and is currently…
-
Tencent Hands Over Two Former CSIG Employees to Authorities on Embezzlement Allegations
•
Chinese internet conglomerate Tencent has announced via its anti-fraud department’s official channel that former employees Zhang Meng and Liu Yunting from the Cloud and Smart Industries Group (CSIG) have been handed over to public security authorities. The two are suspected of misusing their positions to embezzle company assets and to…
-
Tencent’s WeDoctor Teams Up with Guiyang for Digital Health Community Initiative
•
The municipal government of Guiyang has entered into a strategic partnership with WeDoctor Holdings Ltd, a subsidiary of Chinese internet conglomerate Tencent Corporate Venture Capital (HKG: 0700), to establish a digital health community and develop a national demonstration zone in Guiyang. The collaboration also includes the launch of a health…
-
AI-Driven Biotech Insilico Medicine Teams Up with Hutao Tech for Precision Medicine Robotics
•
Insilico Medicine, a China-based biotech company driven by generative artificial intelligence (AI), has entered into a partnership with Hutao Tech, a Beijing-based life science data specialist. The collaboration aims to combine Hutao’s market resources and industry expertise in life science data with Insilico’s AI drug development platform, Pharma AI, and…
-
Meinian Onehealth Collaborates with Huawei Cloud and Runda Medical on AI Health Robot
•
Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a strategic partnership with Huawei Cloud and Shanghai Runda Medical Science and Technology Co., Ltd (SHA: 603108) to develop “Healthy Little Beauty,” a health management artificial intelligence (AI) robot. This initiative marks the creation of China’s first AI robot…
-
Baidu Health and Chongqing’s Fifth People’s Hospital Collaborate on Integrated Medical Services
•
Baidu Health has entered into a partnership with the Fifth People’s Hospital of Chongqing, a Class 3A general hospital in China. The collaboration aims to combine the hospital’s disciplinary and location advantages with Baidu Health’s strengths in online diagnosis, treatment, digitalization, and artificial intelligence (AI) to establish an integrated online-offline…
-
ClouDr Partners with Yangtze River Pharmaceutical to Digitize Chronic Disease Marketing
•
Hangzhou Kang Ming Information Technology Co., Ltd, trading as “ClouDr” (HKG: 9955), has entered into a partnership with fellow Chinese company Yangtze River Pharmaceutical (Group) Co., Ltd. The collaboration will concentrate on providing digitalized marketing services within specific chronic disease sectors, with both parties looking to expand and deepen their…
-
Zeiss Group and China’s Healthcare Cloud Collaborate on Ophthalmic Services in China
•
Germany-based Zeiss Group, a leader in optical systems and optoelectronic product manufacturing, has entered into a partnership with China’s Healthcare Cloud, an online health services provider, during the recent China International Import Expo (CIIE) meeting. The collaboration aims to enhance ophthalmic services in China by leveraging the strengths of both…
-
BMS Secures ORM-6151 for Acute Myeloid Leukemia Treatment with Orum Therapeutics Deal
•
Bristol Myers Squibb (BMS; NYSE: BMY) has made a significant move in the field of oncology by purchasing ORM-6151, a potential first-in-class antibody-drug conjugate (ADC) from US-based Orum Therapeutics. The acquisition includes approval from the local regulator for ORM-6151 to enter a Phase I study for acute myeloid leukemia (AML)…
-
Baidu Launches Interactive AI Medication Instructions Service at Baidu World 2023
•
Robin Li, CEO of China-based internet services giant Baidu, unveiled an innovative interactive AI medication instructions service during the Baidu World 2023 conference earlier this week. This groundbreaking product is the first of its kind in China, designed to utilize the ERNIE GPT bot and Digital Human novel models. The…
-
Baidu Health Partners with HOB Biotech to Innovate Allergy Detection and Treatment
•
Baidu Health has entered into a strategic partnership with HOB Biotech Group, a leading in vitro diagnostic (IVD) specialist in China, to develop a new model that combines allergy detection, desensitization treatment, and Internet+ technologies. The collaboration aims to create a comprehensive approach to allergy management without disclosing financial details.…
